Alcon Inc. (ALC) saw its shares plummet 5.22% in after-hours trading on Tuesday following the release of its first-quarter 2025 financial results that fell short of analyst expectations and a reduction in its full-year guidance.
The eye care company reported Q1 adjusted earnings per share of $0.73, missing the consensus estimate of $0.75. Revenue for the quarter came in at $2.45 billion, below the expected $2.51 billion. Alcon's core operating margin declined to 20.8% from 22.0% in the same period last year, reflecting increased investment in research and development.
Adding to investor concerns, Alcon lowered its 2025 outlook, revising its core operating margin guidance to 20-21% from the previous 21-22%. The company also reduced its core diluted EPS forecast to $3.05-$3.15, down from $3.15-$3.25 previously. CEO David J. Endicott cited a "soft US market" as a challenge, though he expressed optimism about recent product launches, including Unity VCS and PanOptix Pro, which are expected to accelerate growth in the second half of 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.